ABROCITINIB (has an active metabolite) | ABROCITINIB | ATC D11AH08
DERMATOLOGICALS TREATMENT OF ATOPIC DERMATITIS JANUS KINASE 1 (JAK1) INHIBITOR | ORAL | Tmax 1 HOUR F 60 PERCENT VD 100 LITER PPB 64 PERCENT HT 4 HOUR SOLUBILITY 0.04 MILLIGRAM / MILLILITER | JAK1 KINASE PDB 6BBU (CRYSTAL STRUCTURE OF JAK1 IN COMPLEX WITH COMPOUND 25) LIGAND CODE = D7D (link to the list of PDB complexes) Download experimental 3D coordinates of D7D with added hydrogens | Tyrosine-protein kinase JAK1 UNIPROT P23458 more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |